» Authors » Piotr Slupski

Piotr Slupski

Explore the profile of Piotr Slupski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 87
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Borowczak J, Szczerbowski K, Maniewski M, Zdrenka M, Slupski P, Andrusewicz H, et al.
Clin Transl Oncol . 2022 Nov; 25(3):830-840. PMID: 36374405
Purpose: The mutation of p53 is considered a pivotal step in bladder cancer pathogenesis. Recently, distinct interactions between p53 and CDK9, a transcription regulator, have been described. In this work,...
2.
Borowczak J, Szczerbowski K, Maniewski M, Zdrenka M, Slupski P, Antosik P, et al.
Cancers (Basel) . 2022 Mar; 14(6). PMID: 35326643
Introduction: Most patients with urothelial carcinoma are diagnosed with non-invasive tumors, but the prognosis worsens with the progression of the disease. Overexpression of cyclin-dependent kinase 9 has been recently linked...
3.
Jarzemski P, Listopadzki S, Slupski P, Jarzemski M, Brzoszczyk B
Int Braz J Urol . 2020 Mar; 46(4):538-544. PMID: 32213211
The indication for simultaneous bilateral native nephrectomy and the choice of surgical technique is of key importance, as these patients are burdened with a large comorbidity. The paper reports our...
4.
Jarzemski P, Listopadzki S, Slupski P, Jarzemski M, Brzoszczyk B, Sosnowski R
Wideochir Inne Tech Maloinwazyjne . 2020 Mar; 15(1):192-198. PMID: 32117504
Introduction: The important part of radical prostatectomy (RP) for high risk (HR) is extended pelvic lymph node dissection (ePLND). This method consists of two stages of surgery usually performed at...
5.
Sroka W, Boughton B, Reddy P, Roessner U, Slupski P, Jarzemski P, et al.
Eur J Cancer Prev . 2016 May; 26(2):131-134. PMID: 27222937
Prostate cancer is the leading type of cancer diagnosed in men. Serum prostate-specific antigen levels and digital rectal exam are far from perfect when it comes to differentiation of patients...
6.
Sroka W, Adamowski M, Slupski P, Siodmiak J, Jarzemski P, Odrowaz-Sypniewska G, et al.
Int J Biol Markers . 2015 May; 30(4):e401-6. PMID: 25982684
Background: Because of the numerous limitations of prostate-specific antigen (PSA), α-methylacyl-CoA racemase (AMACR) and hepsin have recently been suggested as potential biomarkers in prostate cancer (PC). This report presents a...
7.
Marszall M, Sroka W, Adamowski M, Slupski P, Jarzemski P, Siodmiak J, et al.
Eur J Cancer Prev . 2014 Jul; 24(1):51-6. PMID: 25003607
This study was designed to compare and evaluate the presence of engrailed-2 (EN2) protein in urine collected before and after prostate massage as a diagnostic marker for prostate cancer (PCa)....
8.
Wronski S, Slupski P, Wisniewski P
Cent European J Urol . 2014 Mar; 65(3):124-9. PMID: 24578947
Introduction: This study evaluates the functional outcomes and satisfaction of an initial series of 47 patients after radical perineal prostatectomy performed in our department. Material And Methods: The first set...
9.
Antczak A, Kluzniak W, Wokolorczyk D, Kashyap A, Jakubowska A, Gronwald J, et al.
Gene . 2013 Oct; 532(2):173-6. PMID: 24096176
Background: Germline mutations of BRCA2 and NBS1 genes cause inherited recessive chromosomal instability syndromes and predispose to prostate cancer of poor prognosis. Mutations of the BLM gene cause another chromosomal...
10.
Kashyap A, Kluzniak W, Wokolorczyk D, Golab A, Sikorski A, Slojewski M, et al.
Int J Cancer . 2013 Sep; 134(5):1139-46. PMID: 24037955
Several single nucleotide polymorphisms (SNPs) have been associated with an elevated risk of prostate cancer risk. It is not established if they are useful in predicting the presence of prostate...